Lubiprostone
- Product NDC
- 65162-841
- 11-digit product format
- 651620841
- Labeler code
- 65162
- Product ID
- 65162-841_46db0194-b960-401e-a885-ccb545b72f51
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lubiprostone
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals LLC
- Application
- ANDA209450
- Marketing category
- ANDA
- Marketing start
- 2021-12-03
- Marketing end
- 0000-00-00
- Substance
- LUBIPROSTONE
- Active strength
- 8 ug/1
- Pharmacologic classes
- Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65162-841 | LUBIPROSTONE CAPSULE [AMNEAL PHARMACEUTICALS LLC] | 22 | Legacy NDC | 20241030_333acede-5075-464f-9418-4b22d43eef3c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65162-841-06 | 65162084106 | 60 CAPSULE in 1 BOTTLE (65162-841-06) | 60 capsule | 2021-12-03 | 0000-00-00 | No | No | Current |
| 65162-841-18 | 65162084118 | 180 CAPSULE in 1 BOTTLE (65162-841-18) | 180 capsule | 2021-12-03 | 0000-00-00 | No | No | Current |